DHR
Danaher Corporation
NYSE · USD · Stock
$232.23
+6.12 (+2.71%)
past month
Closed- Market cap
- $163.25B
- P/E
- 38.45
- Yield
- 0.69%
- Volume
- 3.7M
- 52 weeks
- $161 – $243
- Dividend
About
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments.
Danaher Corporation (DHR) is a healthcare company listed on NYSE, traded in USD. Over the past year it moved between $160.93 and $242.80, and it pays a dividend every quarter.
- Healthcare
- Diagnostics & Research
- Washington, United States
- 58K employees
- Led by Steven M. Rales
Financials
Revenue, last 12 months
$25.61B+8.30%
Earnings
Beat the estimate
4 of 4 quarters
Q4 2025
+1.99%
Q1 2026
+6.45%
Q2 2026
+5.28%
Q3 2026
+10.02%
Earnings per share, last 12 months $6.04
Analysts
21 analysts say
Strong buy
12-month target$259.90+11.92%
Dividends
Yield · per share, yearly
0.69%$1.60
Split 1,128-for-1,000 on Oct 2, 2023
Ownership
- Institutions
- 83.64%
- Insiders
- 10.81%
Latest insider trade Oct 28, 2026, BOUDA CHRISTOPHER
Prices from Yahoo Finance, may be delayed
